Evidence map›Paper›PMID 25007263›Full record

ArticlePloS one2014

Transient and persistent metabolomic changes in plasma following chronic cigarette smoke exposure in a mouse model.

Charmion I Cruickshank-Quinn, Spencer Mahaffey, Matthew J Justice, Grant Hughes, Michael Armstrong, Russell P Bowler, Richard Reisdorph, Irina Petrache, Nichole Reisdorph

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Pharmacological sphingosine-1 phosphate receptor 1 targeting in cigarette smoke-induced emphysema in mice.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Resolvin E1 derived from eicosapentaenoic acid prevents hyperinsulinemia and hyperglycemia in a host genetic manner.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Charmion I Cruickshank-QuinnIntegrated Department of Immunology, National Jewish Health and University of Colorado School of Medicine, Denver, Colorado, United States of America.
Spencer MahaffeyIntegrated Department of Immunology, National Jewish Health and University of Colorado School of Medicine, Denver, Colorado, United States of America; Department of Pharmacology, School of Medicine, University of Colorado Denver, Aurora, Colorado, United States of America.
Matthew J JusticeDepartments of Medicine and of Biochemistry and Molecular Biology, Indiana University, Indianapolis, Indiana, United States of America.
Grant HughesDepartment of Biostatistics and Informatics, University of Colorado Denver, Aurora, Colorado, United States of America.
Michael ArmstrongIntegrated Department of Immunology, National Jewish Health and University of Colorado School of Medicine, Denver, Colorado, United States of America.
Russell P BowlerDepartment of Medicine, National Jewish Health, Denver, Colorado, United States of America.
Richard ReisdorphIntegrated Department of Immunology, National Jewish Health and University of Colorado School of Medicine, Denver, Colorado, United States of America; Department of Pediatrics, National Jewish Health, Denver, Colorado, United States of America.
Irina PetracheDepartments of Medicine and of Biochemistry and Molecular Biology, Indiana University, Indianapolis, Indiana, United States of America; Richard L. Roudebush VA Medical Center, Indianapolis, Indiana, United States of America.
Nichole ReisdorphIntegrated Department of Immunology, National Jewish Health and University of Colorado School of Medicine, Denver, Colorado, United States of America.
University of Colorado Denver · USNational Jewish Health · USIndiana University – Purdue University Indianapolis · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
(2 of 2) Genetic Epidemiology of COPDR01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2012 to 2016
$18.9M
Ceramide-induced Lung Destruction in EmphysemaR01HL077328 · NHLBI · NATIONAL JEWISH HEALTH · PI PETRACHE, IRINA · 2006 to 2024
$8.0M
Metabolic profiles of COPD phenotypesP20HL113445 · NHLBI · NATIONAL JEWISH HEALTH · PI BOWLER, RUSSELL PAUL · 2012 to 2016
$4.7M
Metabolome and proteome profiles of emphysema and airway diseaseR01HL095432 · NHLBI · NATIONAL JEWISH HEALTH · PI BOWLER, RUSSELL PAUL · 2009 to 2012
$1.6M
Direct and Bone-Marrow Mediated Effects of Adipose Stem Cells in EmphysemaR01HL105772 · NHLBI · NATIONAL JEWISH HEALTH · PI MARCH, KEITH LEONARD, PETRACHE, IRINA · 2012 to 2015
$1.5M
Sphingolipids and inflammatory biomarkers of COPD progression in healthy smokersR01HL129937 · NHLBI · NATIONAL JEWISH HEALTH · PI BOWLER, RUSSELL PAUL · 2015 to 2017
$1.3M
NCATS NIH HHS UL1 TR001082NCRR NIH HHS UL1 RR025780NHLBI NIH HHS P20 HL113445NHLBI NIH HHS P20 HL-113445-01NHLBI NIH HHS R01 HL077328NHLBI NIH HHS R01 HL089856NHLBI NIH HHS R01 HL095432NHLBI NIH HHS R01HL 095432NHLBI NIH HHS R01 HL105772NHLBI NIH HHS R01 HL129937NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897
6 · The paper itself

Abstract

Cigarette smoke exposure is linked to the development of a variety of chronic lung and systemic diseases in susceptible individuals. Metabolomics approaches may aid in defining disease phenotypes, may help predict responses to treatment, and could identify biomarkers of risk for developing disease. Using a mouse model of chronic cigarette smoke exposure sufficient to cause mild emphysema, we investigated whether cigarette smoke induces distinct metabolic profiles and determined their persistence following smoking cessation. Metabolites were extracted from plasma and fractionated based on chemical class using liquid-liquid and solid-phase extraction prior to performing liquid chromatography mass spectrometry-based metabolomics. Metabolites were evaluated for statistically significant differences among group means (p-value≤0.05) and fold change ≥1.5). Cigarette smoke exposure was associated with significant differences in amino acid, purine, lipid, fatty acid, and steroid metabolite levels compared to air exposed animals. Whereas 60% of the metabolite changes were reversible, 40% of metabolites remained persistently altered even following 2 months of smoking cessation, including nicotine metabolites. Validation of metabolite species and translation of these findings to human plasma metabolite signatures induced by cigarette smoking may lead to the discovery of biomarkers or pathogenic pathways of smoking-induced disease.

Indexed as

AnimalsBiomarkersDisease Models, AnimalGas Chromatography-Mass SpectrometryHumansMaleMetabolomicsMicePulmonary EmphysemaSmokingBiomarkers

Identifiers

PMID25007263
PMCPMC4090193
OpenAlexW2065127110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.